No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study

References

• Bielinski SJ, St Sauver JL, Olson JE, et al. Cohort Profile: the right drug, right dose, right time: using genomic data to individualize treatment protocol (RIGHT protocol). Int J Epidemiol. 2020;49(1):23–24k. doi:10.1093/ije/dyz123
   Web of Science ®Google Scholar
• Porter ME, Pabo EA, Lee TH. Redesigning primary care: a strategic vision to improve value by organizing around patients’ needs. Health Aff (Millwood). 2013;32(3):516–525. doi:10.1377/hlthaff.2012.0961
   PubMed Web of Science ®Google Scholar
• Clough JD, Riley GF, Cohen M, et al. Patterns of care for clinically distinct segments of high cost Medicare beneficiaries. Healthc (Amst). 2016;4(3):160–165. doi:10.1016/j.hjdsi.2015.09.005
   Google Scholar
• Boult C, Dowd B, McCaffrey D, Boult L, Hernandez R, Krulewitch H. Screening elders for risk of hospital admission. J Am Geriatr Soc. 1993;41(8):811–817. doi:10.1111/j.1532-5415.1993.tb06175.x
   PubMed Web of Science ®Google Scholar
• Crane SJ, Tung EE, Hanson GJ, Cha S, Chaudhry R, Takahashi PY. Use of an electronic administrative database to identify older community dwelling adults at high-risk for hospitalization or emergency department visits: the elders risk assessment index. BMC Health Serv Res. 2010;10:338. doi:10.1186/1472-6963-10-338
   Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Abdel-Qadir H, Thavendiranathan P, Austin PC, et al. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study. Eur Heart J. 2019. doi:10.1093/eurheartj/ehz460
   Web of Science ®Google Scholar
• Takahashi PY, Ryu E, Olson JE, et al. Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank. Int J Gen Med. 2015;8:247–254. doi:10.2147/IJGM.S85473
   Google Scholar
• Takahashi PY, Ryu E, Hathcock MA, et al. A novel housing-based socioeconomic measure predicts hospitalisation and multiple chronic conditions in a community population. J Epidemiol Community Health. 2016;70(3):286–291. doi:10.1136/jech-2015-205925
   PubMed Web of Science ®Google Scholar
• Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–2481. doi:10.1056/NEJMp1011024
   PubMed Web of Science ®Google Scholar
• Haas LR, Takahashi PY, Shah ND, et al. Risk-stratification methods for identifying patients for care coordination. Am J Manag Care. 2013;19(9):725–732.
   PubMed Web of Science ®Google Scholar
• Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012. doi:10.1056/NEJMsa1103053
   PubMed Web of Science ®Google Scholar
• Thorsteinsdottir B, Peterson SM, Naessens JM, et al. Care transitions program for high-risk frail older adults is most beneficial for patients with cognitive impairment. J Hosp Med. 2019;14:E1–E8.
   Web of Science ®Google Scholar
• Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol a Biol Sci Med Sci. 2000;55(10):M554–M559. doi:10.1093/gerona/55.10.M554
   Web of Science ®Google Scholar
• Budnitz DS, Lovegrove MC, Crosby AE. Emergency department visits for overdoses of acetaminophen-containing products. Am J Prev Med. 2011;40(6):585–592. doi:10.1016/j.amepre.2011.02.026
   PubMed Web of Science ®Google Scholar
• By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2019 updated AGS beers criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.15767
   PubMed Web of Science ®Google Scholar
• Weinshilboum RM, Wang L. Pharmacogenomics: precision medicine and drug response. Mayo Clin Proc. 2017;92(11):1711–1722. doi:10.1016/j.mayocp.2017.09.001
   PubMed Web of Science ®Google Scholar
• Ji Y, Skierka JM, Blommel JH, et al. Preemptive pharmacogenomic testing for precision medicine: a comprehensive analysis of five actionable pharmacogenomic genes using next-generation DNA sequencing and a customized CYP2D6 genotyping cascade. J Mol Diagn. 2016;18(3):438–445. doi:10.1016/j.jmoldx.2016.01.003
   PubMed Web of Science ®Google Scholar
• Bielinski SJ, Olson JE, Pathak J, et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc. 2014;89(1):25–33. doi:10.1016/j.mayocp.2013.10.021
   PubMed Web of Science ®Google Scholar
• Takahashi PY, Ryu E, Pathak J, et al. Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6. Pharmgenomics Pers Med. 2017;10:39–47. doi:10.2147/PGPM.S114211
   Web of Science ®Google Scholar
• Leary E, Brilliant M, Peissig P, Griesbach S. Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center. Am J Health Syst Pharm. 2019;76(6):387–397. doi:10.1093/ajhp/zxy072
   Web of Science ®Google Scholar
• Nofziger C, Turner AJ, Sangkuhl K, et al. PharmVar GeneFocus: CYP2D6. Clin Pharmacol Ther. 2020;107(1):154–170. doi:10.1002/cpt.1643
   PubMed Web of Science ®Google Scholar
• Devarajan S, Moon I, Ho MF, et al. Pharmacogenomic next-generation DNA sequencing: lessons from the identification and functional characterization of variants of unknown significance in CYP2C9 and CYP2C19. Drug Metab Dispos. 2019;47(4):425–435. doi:10.1124/dmd.118.084269
   PubMed Web of Science ®Google Scholar
• Lauschke VM, Ingelman-Sundberg M. The importance of patient-specific factors for hepatic drug response and toxicity. Int J Mol Sci. 2016;17(10):1714. doi:10.3390/ijms17101714
   Web of Science ®Google Scholar
• Olson JE, Ryu E, Hathcock MA, et al. Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile. BMJ Open. 2019;9(11):e032707. doi:10.1136/bmjopen-2019-032707
   Web of Science ®Google Scholar
• Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ 3rd. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87(12):1202–1213. doi:10.1016/j.mayocp.2012.08.012
   PubMed Web of Science ®Google Scholar
• Wu P, Gifford A, Meng X, et al. Developing and evaluating mappings of ICD-10 and ICD-10-CM codes to PheCodes. JMIR Med Inform. 2019;7(4):e14325. doi:10.2196/14325
   Web of Science ®Google Scholar
• Wei WQ, Bastarache L, Carroll RJ, et al. Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record. PLoS One. 2017;12(7):e0175508. doi:10.1371/journal.pone.0175508
   Web of Science ®Google Scholar
• Goodman RA, Boyd C, Tinetti ME, Von Kohorn I, Parekh AK, McGinnis JM. IOM and DHHS meeting on making clinical practice guidelines appropriate for patients with multiple chronic conditions. Ann Fam Med. 2014;12(3):256–259. doi:10.1370/afm.1646
   Web of Science ®Google Scholar
• Rocca WA, Boyd CM, Grossardt BR, et al. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc. 2014;89(10):1336–1349. doi:10.1016/j.mayocp.2014.07.010
   PubMed Web of Science ®Google Scholar
• Schultz R, Eden J. Families Caring for an Aging America. Washington, DC: National Academies Press; 2016.
   Google Scholar
• Juhn YJ, Qin R, Urm S, Katusic S, Vargas-Chanes D. The influence of neighborhood environment on the incidence of childhood asthma: a propensity score approach. J Allergy Clin Immunol. 2010;125(4):838–843 e832. doi:10.1016/j.jaci.2009.12.998
   PubMed Web of Science ®Google Scholar
• Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017;19(1):69–76. doi:10.1038/gim.2016.80
   PubMed Web of Science ®Google Scholar
• Shelton P, Sager MA, Schraeder C. The community assessment risk screen (CARS): identifying elderly persons at risk for hospitalization or emergency department visit. Am J Manag Care. 2000;6(8):925–933.
   PubMed Web of Science ®Google Scholar
• Reuben DB, Keeler E, Seeman TE, Sewall A, Hirsch SH, Guralnik JM. Development of a method to identify seniors at high risk for high hospital utilization. Med Care. 2002;40(9):782–793. doi:10.1097/00005650-200209000-00008
   Web of Science ®Google Scholar
• Calvillo-King L, Arnold D, Eubank KJ, et al. Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med. 2013;28(2):269–282. doi:10.1007/s11606-012-2235-x
   PubMed Web of Science ®Google Scholar
• Takahashi PY, Ryu E, Olson JE, et al. Hospitalizations and emergency department use in Mayo Clinic Biobank participants within the employee and community health medical home. Mayo Clin Proc. 2013;88(9):963–969. doi:10.1016/j.mayocp.2013.06.015
   Web of Science ®Google Scholar
• Ann Moyer MDP. CYP 2d6. In: phD JO, ed; 2020.
   Google Scholar
• Kneller LA, Abad-Santos F, Hempel G. Physiologically based pharmacokinetic modelling to describe the pharmacokinetics of risperidone and 9-hydroxyrisperidone according to cytochrome P450 2D6 phenotypes. Clin Pharmacokinet. 2020;59(1):51–65. doi:10.1007/s40262-019-00793-x
   Web of Science ®Google Scholar
• Chen R, Wang H, Shi J, Shen K, Hu P. Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems. Eur J Clin Pharmacol. 2015;71(7):835–841. doi:10.1007/s00228-015-1855-6
   Web of Science ®Google Scholar
• Dagostino C, Allegri M, Napolioni V, et al. CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort. Pharmgenomics Pers Med. 2018;11:179–191. doi:10.2147/PGPM.S181334
   PubMed Web of Science ®Google Scholar
• Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin Pharmacokinet. 2009;48(11):689–723.
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Delle-Karth G, Lang IM, et al. Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study. J Thromb Haemost. 2012;10(4):529–542. doi:10.1111/j.1538-7836.2012.04639.x
   PubMed Web of Science ®Google Scholar
• Mega JL, Simon T, Collet JP, et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010;304(16):1821–1830. doi:10.1001/jama.2010.1543
   PubMed Web of Science ®Google Scholar
• Perlis RH, Mehta R, Edwards AM, Tiwari A, Imbens GW. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: a propensity-score matched study. Depress Anxiety. 2018;35(10):946–952. doi:10.1002/da.22742
   Web of Science ®Google Scholar
• Battig VAD, Roll SC, Hahn M. Pharmacogenetic testing in depressed patients and interdisciplinary exchange between a pharmacist and psychiatrists results in reduced hospitalization times. Pharmacopsychiatry. 2020;53(4):185–192. doi:10.1055/a-1096-1171
   Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Brue SM, et al. Data resource profile: expansion of the Rochester epidemiology project medical records-linkage system (E-REP). Int J Epidemiol. 2018;47(2):368–368j. doi:10.1093/ije/dyx268
   PubMed Web of Science ®Google Scholar
• Caraballo PJ, Sutton JA, Giri J, et al. Integrating pharmacogenomics into the electronic health record by implementing genomic indicators. J Am Med Inform Assoc. 2019. doi:10.1093/jamia/ocy156
   Web of Science ®Google Scholar
• St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester epidemiology project. Mayo Clin Proc. 2012;87(2):151–160. doi:10.1016/j.mayocp.2011.11.009
   PubMed Web of Science ®Google Scholar